News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

University launches new biotech spin-out company

Jun 28th 2024
The University of Liverpool has launched a new biotech spin-out company to develop novel therapeutic drugs for the treatment of cancer and fibrotic diseases.
Read More

University plays key role in Investment Zone plans

Mar 18th 2024
The University of Liverpool has been a vital contributor to the Liverpool City Region’s Investment Zone plans. Announced today, these plans will supercharge health and life sciences.
Read More

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the tre...

Jan 5th 2024
Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease
Read More

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients wit...

Oct 24th 2023
PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...
Read More

PharmaKure announces study success for novel blood test to identify biomarkers i...

Oct 17th 2023
Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease
Read More

PharmaKure and APIS Assay Technologies Sign a Collaboration for the Development ...

Jul 3rd 2023
PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker trans...
Read More

PharmaKure Announces Successful Scientific Advice Meeting with the MHRA

Feb 6th 2023
With approval of MHRA to submit a CTA, PharmaKure is now well positioned to advance towards its clinical trial programme that is essential to market authorisation
Read More

PharmaKure has launched a study to identify blood-based biomarkers in patients w...

Oct 4th 2022
PharmaKure has launched a study to examine the relationship between blood biomarkers and historical PET scans or CSF in patients with Mild Cognitive Impairment due to Alzheimer’s Disease.
Read More

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Apr 14th 2022
The Newcastle based agency Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solution...
Read More

New study into cancer cells to help improve chemotherapy effectiveness

Mar 2nd 2022
A new Liverpool led study, published in Gut, has identified how immune cells in the body can promote the regrowth of cancer cells after chemotherapy withdrawal. These findings will help impr...
Read More

Grant Opportunities in Life Science Sector

Jun 24th 2021
The Markel Grants Team provide expert support in writing and securing funding for new product development. Markel have partnered with Bionow for several years, providing expert support and a...
Read More

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug di...

Dec 21st 2020
Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners